RxDoctor Payments Data

Naomi Nakao

New York, NYNPI 1952468852

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $494,484 of the $632,024 with a category attached, or 78.2%. Conmed Corporation accounts for 76.4% of it on its own, with 2 other manufacturers making up the rest.

$632,024in general payments, 2019–2025

Across 61 payments — averaging $10,361 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Conmed Corporation$483K
  • Stryker$143K
  • Linvatec Corporation$6K

What the payments were for

  • Royalty or licence$494,48478%
  • Grants$137,54022%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Conmed Corporation42$483,066
Stryker18$142,617
Linvatec Corporation1$6,341

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →